Pal, Krishnendu <br/><br/>
Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC.  [electronic resource] 

 -  International journal of nanomedicine  2019 
 - 5109-5123 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1178-2013 
<br/><br/><label>Standard No.: </label>10.2147/IJN.S204221  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Compounding<br/>Drug Delivery Systems--methods<br/>Everolimus--administration & dosage<br/>Humans<br/>Ki-67 Antigen--metabolism<br/>Kidney Neoplasms--drug therapy<br/>Liposomes<br/>Lung Neoplasms--secondary<br/>Mice, SCID<br/>Phosphatidylethanolamines--chemistry<br/>Polyethylene Glycols--chemistry<br/>Tissue Distribution<br/>Vinorelbine--administration & dosage<br/>Xenograft Model Antitumor Assays